Tokyo, Sept. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062851) titled 'An Exploratory Study on the Improvement of Overall Health Status through the Functional Beverages' on Sept. 8.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - Integrated Health Science Co., Ltd.

Condition: Condition - Healthy Adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the effects of functional beverage consumption on overall health improvement. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Ingestion of the test beverage.

Eligibility: Age-lower limit - 20 years-old = Gender - Male and Female Key inclusion criteria - 1. Individuals aged 20 to 65 years who do not meet any of the exclusion criteria. 2. Individuals who understand the informed consent information and are able to provide voluntary written consent. Key exclusion criteria - 1.Individuals with a history of serious diseases related to the brain, nervous system, cardiovascular system, or other severe conditions, or those currently undergoing treatment, including those taking prescribed medication. 2. Individuals with a history of seizures (such as loss of consciousness, coma, or convulsions) due to neurological disorders. 3. Individuals currently suffering from peptic ulcers (such as gastric ulcers). 4.Individuals who have difficulty performing essential evaluation items in this study due to hearing or visual impairments. 5. Individuals who are currently pregnant or breastfeeding. 6. Individuals with food allergies. 7. Individuals who consumed functional beverages three or more times per week within one monthprior to providing informed consent. 8. Individuals who are currently participating in another clinical study or who participated in another interventional clinical study within one month prior to providing informed consent. 9.Individuals judged as inappropriate for participation by the principal investigator. Target Size - 60

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 08 Month 18 Day Date of IRB - 2026 Year 08 Month 19 Day Anticipated trial start date - 2026 Year 09 Month 08 Day Last follow-up date - 2026 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071943

Disclaimer: Curated by HT Syndication.